Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review on Coronavirus Disease 2019 (Covid-19) in Pediatric Patients Publisher



Moghadam SO1 ; Afshar D2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Source: Archives of Pediatric Infectious Diseases Published:2020


Abstract

Context: A series of unexplained pneumonia cases were first reported as of December 2019, in Wuhan, China. Official names have been announced for the novel human coronavirus responsible for the pneumonia outbreak in China, and the disease it causes has been announced Coronavirus Disease 2019 (COVID-19). Despite great efforts worldwide to control the SARS-CoV-2 outbreak, the spread of the virus has recently reached a pandemic. Currently, infection prevention and control of this virus are the primary concerns for public health officials and professionals. In this review, the current status of epidemiology, diagnosis, and potential treatment options of SARS-CoV-2 infection in children and the possible reasons for milder presentations of COVID-19 in children than in adults were discussed to provide an insight into the further characterization of COVID-19 in children. Evidence Acquisition: The most recent evidence about the clinical features and potential reasons for the non-susceptibility of children to SARS-CoV-2 infection have been provided in the present narrative review. A systematic search was performed in some databases/search engines, including ISI Web of Science, Scopus, PubMed, and Google Scholar. Then, the relevant published articles were reviewed. The keywords utilized for finding related articles were Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), pediatric, COVID-19, treatment, Angiotensin-Converting Enzyme 2 (ACE2), clinical feature, coronavirus, and pneumonia. Results: Based on the findings, respiratory infections caused by the virus are more frequent in children aged five years or younger than in other age groups. However, the currently available data suggest that COVID-19 infection in children seems to be uncommon. Moreover, in the case of infection with SARS-CoV-2, the disease presentation is frequently milder than in adults and the overall burden in children was reported to be relatively low. Conclusions: Several explanations have been suggested to justify the milder symptoms in children than in adults, including differences in immunity systems of children and adults and differences in ACE2 expression as a receptor for virus attachment. Moreover, while children tend to present mild symptoms of infection, their role in the spread of the disease in the community should not be ignored. © 2020, Author(s).
Other Related Docs
11. Covid-19 in Neonates: A Review, Iranian Journal of Pediatrics (2021)
17. Transmission Modes of Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2021)
19. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
21. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
22. Corona in Infants: New Drugs and Vaccinations for Mothers, Pakistan Journal of Medical and Health Sciences (2020)
24. Care of Newborns Born to Mothers With Covid-19 Infection; a Review of Existing Evidence, Journal of Maternal-Fetal and Neonatal Medicine (2022)
25. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
30. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)
31. Covid-19 Considerations in Pediatric Dentistry, JDR Clinical and Translational Research (2020)
35. Bibliometric Analysis of Global Scientific Research on Coronavirus (Covid-19), Medical Journal of the Islamic Republic of Iran (2020)
48. Management of Environmental Health to Prevent an Outbreak of Covid-19: A Review, Environmental and Health Management of Novel Coronavirus Disease (COVID-19) (2021)